Keck School Faculty

Toby Maher
Toby Maher
Professor of Clinical Medicine
Medicine
1520 San Pablo Street Health Sciences Campus Los Angeles

Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease Eur Respir J. 2019 Nov 14. . View in PubMed

Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis Am J Respir Crit Care Med. 2019 Nov 11. . View in PubMed

Cost-effectiveness of Ambulatory Oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial Eur Respir J. 2019 Nov 07. . View in PubMed

Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design Adv Ther. 2019 Nov; 36(11):3059-3070. . View in PubMed

Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis Am J Respir Crit Care Med. 2019 Nov 01; 200(9):1146-1153. . View in PubMed

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial Lancet Respir Med. 2019 Sep 27. . View in PubMed

Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis Sci Transl Med. 2019 Sep 25; 11(511). . View in PubMed

Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat Respir Res. 2019 Sep 06; 20(1):205. . View in PubMed

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study Lancet Respir Med. 2019 Sep; 7(9):771-779. . View in PubMed

Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis Eur Respir J. 2019 Sep; 54(3). . View in PubMed

King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference Eur Respir J. 2019 Sep; 54(3). . View in PubMed

Overlap of Genetic Risk Between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis Am J Respir Crit Care Med. 2019 Jul 24. . View in PubMed

Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort Respir Res. 2019 Jul 12; 20(1):148. . View in PubMed

Management of Fibrosing Interstitial Lung Diseases Adv Ther. 2019 Jul; 36(7):1518-1531. . View in PubMed

Can monocytes predict prognosis of idiopathic pulmonary fibrosis? Lancet Respir Med. 2019 Jun; 7(6):467-469.. View in PubMed

Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort Eur Respir J. 2019 May; 53(5). . View in PubMed

In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality Eur Respir J. 2019 May; 53(5). . View in PubMed

A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis Eur Respir J. 2019 Mar; 53(3). . View in PubMed

Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use Pharmacoecon Open. 2019 Mar; 3(1):81-91. . View in PubMed

Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study Eur Respir J. 2019 Feb; 53(2). . View in PubMed

Idiopathic Pulmonary Fibrosis: New and Emerging Treatment Options Drugs Aging. 2019 06; 36(6):485-492. . View in PubMed

Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis Respir Med. 2019 01; 146:42-48. . View in PubMed

No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidone Eur Respir J. 2019 Jan; 53(1). . View in PubMed

Computed Tomographic Biomarkers in Idiopathic Pulmonary FibrosisThe Future of Quantitative Analysis. Am J Respir Crit Care Med. 2019 01 01; 199(1):12-21. . View in PubMed

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease N Engl J Med. 2019 06 27; 380(26):2518-2528. . View in PubMed

Could quality be the key in connective tissue disease-associated interstitial lung disease? Respirology. 2018 Jun 13.. View in PubMed

Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK Adv Ther. 2018 May; 35(5):724-736. . View in PubMed

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial Lancet Respir Med. 2018 10; 6(10):759-770. . View in PubMed

Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema Respirology. 2018 06; 23(6):593-599. . View in PubMed

Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis Respirology. 2018 05; 23(5):498-506. . View in PubMed

Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views Respiration. 2018; 96(6):514-524. . View in PubMed

Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis Respiration. 2018; 96(4):314-322. . View in PubMed

Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial BMJ Open Respir Res. 2018; 5(1):e000325. . View in PubMed

Combination Therapy and the Start of a New Epoch for Idiopathic Pulmonary Fibrosis? Am J Respir Crit Care Med. 2018 02 01; 197(3):283-284.. View in PubMed

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume Thorax. 2017 Apr; 72(4):340-346. . View in PubMed

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study Lancet Respir Med. 2017 12; 5(12):946-955. . View in PubMed

A lesson in plasticity: a 74-year-old man with plastic bronchitis Thorax. 2017 11; 72(11):1055-1057. . View in PubMed

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study Lancet Respir Med. 2017 11; 5(11):869-880. . View in PubMed

Cough in fibrotic lung disease: An unresolved challenge Respirology. 2017 11; 22(8):1491-1492. . View in PubMed

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial Lancet Respir Med. 2017 10; 5(10):806-815. . View in PubMed

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study Eur Respir J. 2017 08; 50(2). . View in PubMed

Home spirometry for idiopathic pulmonary fibrosis: ready for prime time? Eur Respir J. 2017 07; 50(1).. View in PubMed

Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis Eur Respir J. 2017 07; 50(1). . View in PubMed

A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK Pharmacoeconomics. 2017 04; 35(4):479-491. . View in PubMed

Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis Thorax. 2017 02; 72(2):148-153. . View in PubMed

Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis Am J Respir Crit Care Med. 2017 06 15; 195(12):1640-1650. . View in PubMed

Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone Respiration. 2017; 93(6):415-423. . View in PubMed

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis Respir Res. 2017 02 01; 18(1):29. . View in PubMed

Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial Trials. 2017 04 28; 18(1):201. . View in PubMed

Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted Respir Med. 2016 11; 120:131-133. . View in PubMed

Medicine and Me: a breath of fresh air for IPF Lancet Respir Med. 2016 08; 4(8):615-616. . View in PubMed

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF Thorax. 2016 08; 71(8):701-11. . View in PubMed

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis Lancet Respir Med. 2016 05; 4(5):381-9. . View in PubMed

Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia BMC Genet. 2016 06 07; 17(1):74. . View in PubMed

Acute Exacerbation of Idiopathic Pulmonary FibrosisAn International Working Group Report. Am J Respir Crit Care Med. 2016 08 01; 194(3):265-75. . View in PubMed

Fantasy or Reality? Am J Respir Crit Care Med. 2016 11 15; 194(10):1182-1184.. View in PubMed

Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis Am J Respir Crit Care Med. 2016 10 15; 194(8):989-997. . View in PubMed

An Unexplored Realm in the Search for Fibrosis Therapies? Am J Respir Crit Care Med. 2015 Dec 15; 192(12):1407-9.. View in PubMed

Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique Adv Ther. 2015 Oct; 32(10):929-43. . View in PubMed

New guideline on treatment of idiopathic pulmonary fibrosis Lancet Respir Med. 2015 Sep; 3(9):e31-e32. . View in PubMed

Personalized medicine in idiopathic pulmonary fibrosis: facts and promises Curr Opin Pulm Med. 2015 Sep; 21(5):470-8. . View in PubMed

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study Lancet Respir Med. 2015 Jun; 3(6):462-72. . View in PubMed

Nintedanib in idiopathic pulmonary fibrosis Drugs Today (Barc). 2015 Jun; 51(6):345-56. . View in PubMed

Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis Eur Respir Rev. 2015 Mar; 24(135):58-64. . View in PubMed

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives Biomed Res Int. 2015; 2015:329481. . View in PubMed

Combination therapy: the future of management for idiopathic pulmonary fibrosis? Lancet Respir Med. 2014 Nov; 2(11):933-942.. View in PubMed

Can we do better? Respirology. 2014 Nov; 19(8):1095-6.. View in PubMed

Case-based discussion from the Royal Devon and Exeter NHS Foundation Trust: a painful paradox Thorax. 2014 Aug; 69(8):779-81. . View in PubMed

Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia Am J Respir Crit Care Med. 2014 Jul 15; 190(2):208-17. . View in PubMed

Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era? Eur Respir J. 2014 May; 43(5):1233-6.. View in PubMed

Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events Adv Ther. 2014 Apr; 31(4):375-91. . View in PubMed

Immunosuppression for connective tissue disease-related pulmonary disease Semin Respir Crit Care Med. 2014 Apr; 35(2):265-73. . View in PubMed

Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis Thorax. 2014 Mar; 69(3):287-8. . View in PubMed

An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study Lancet Respir Med. 2014 Feb; 2(2):123-30. . View in PubMed

Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients Eur J Nucl Med Mol Imaging. 2014 Feb; 41(2):337-42. . View in PubMed

Beyond the diagnosis of idiopathic pulmonary fibrosis; the growing role of systems biology and stratified medicine Curr Opin Pulm Med. 2013 Sep; 19(5):460-5. . View in PubMed

Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease Respir Res. 2013 Aug 02; 14:80. . View in PubMed

Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment Thorax. 2013 Aug; 68(8):780-1. . View in PubMed

Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis Eur Respir J. 2013 Jul; 42(1):230-8. . View in PubMed

Exercise-induced haemoptysis: a thoroughbred cause? Thorax. 2013 Jun; 68(6):599-600.. View in PubMed

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis Thorax. 2013 May; 68(5):436-41. . View in PubMed

Obliterative bronchiolitis in fibreglass workers: a new occupational disease? Occup Environ Med. 2013 May; 70(5):357-9.. View in PubMed

A clinical approach to diffuse parenchymal lung disease Immunol Allergy Clin North Am. 2012 Nov; 32(4):453-72. . View in PubMed

Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: incidence, all-cause mortality and characteristics at diagnosis Respirology. 2012 Jul; 17(5):861-8. . View in PubMed

18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials Eur J Nucl Med Mol Imaging. 2012 Mar; 39(3):521-8. . View in PubMed

Elevated nocturnal desaturation index predicts mortality in interstitial lung disease Sarcoidosis Vasc Diffuse Lung Dis. 2012 Mar; 29(1):41-50. . View in PubMed

Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment Clin Chest Med. 2012 Mar; 33(1):69-83. . View in PubMed

In search of the fibrotic epithelial cell: opportunities for a collaborative network Thorax. 2012 Feb; 67(2):179-82. . View in PubMed

Diffuse cystic lung disease of unexplained cause with coexistent small airway disease: a possible causal relationship? Am J Surg Pathol. 2012 Feb; 36(2):228-34.. View in PubMed

Current and novel drug therapies for idiopathic pulmonary fibrosis Drug Des Devel Ther. 2012; 6:261-72. . View in PubMed

Ambulatory oxygen in interstitial lung disease Eur Respir J. 2011 Oct; 38(4):987-90. . View in PubMed

Idiopathic pulmonary fibrosis-related pulmonary hypertension; an exercising diagnosis? Respirology. 2011 Apr; 16(3):381-3.. View in PubMed

If it was good enough for Aristotle. . . . . Thorax. 2011 Mar; 66(3):183-84. . View in PubMed

Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis Am J Respir Crit Care Med. 2010 Jul 01; 182(1):73-82. . View in PubMed

Pirfenidone in idiopathic pulmonary fibrosis Drugs Today (Barc). 2010 Jul; 46(7):473-82. . View in PubMed

Lost in translation; from animal models of pulmonary fibrosis to human disease Respirology. 2009 Sep; 14(7):915-6. . View in PubMed

Optimal treatment for idiopathic pulmonary fibrosis Thorax. 2008 Dec; 63(12):1120-1; author reply 1121. . View in PubMed

Interstitial lung disease in systemic sclerosis: a simple staging system Am J Respir Crit Care Med. 2008 Jun 01; 177(11):1248-54. . View in PubMed

Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J. 2007 Nov; 30(5):835-9.. View in PubMed

CT findings of varicella pneumonia after lung transplantation AJR Am J Roentgenol. 2007 Jun; 188(6):W557-9. . View in PubMed

Powered by SC CTSI
Go to Top